Researchers investigated the relationship between state COVID-19 vaccination mandates for healthcare workers and vaccination rates among them.
Ascidian Therapeutics raises $40m to advance drug development
Ascidian’s lead programme is an RNA exon editor, which can potentially prevent the progression of ABCA4 retinopathies. Credit: fizkes / Shutterstock.com. Ascidian Therapeutics has raised $40m